Who We Are

Le Lai Wa International Fertility has been operating for 8 years, dedicated to providing global fertility medical consultation, infertility counseling, and personalized fertility planning services, along with comprehensive medical consulting. Our services cover the United States, Thailand, Georgia, Kyrgyzstan, Malaysia, Russia, Cambodia, Colombia and other countries, with branch offices in major Chinese cities such as Beijing and Shanghai. We are today one of the most professional integrated domestic-and-overseas service providers and the most dedicated overseas assisted-reproductive service providers in China. With a professional and attentive approach, we have built a strong reputation in the overseas assisted-reproductive industry and have served more than 50,000 clients.

Professional team focused on

medical-health internet products

Zhongguancun High-Tech Enterprise

Holding multiple proprietary intellectual properties

Corporate Authorization Certificates

Cooperation Letter of Attorney from Bangluan Hospital in Thonburi, Thailand

Letter of authorization for cooperation with EKI-IVF

Letter of authorization for cooperation with DHC Reproductive Hospital in Thailand

Superior A.R.T. Cooperation Agreement

Letter of authorization from Envida Reproductive Center

Letter of authorization from Mizuho Reproductive Hospital, Japan

Ten Core Advantages

Why Partner With Us

Vast Market, Hundred-Billion Scale

Statistics show that by 2023, about 18.2% of couples encountered infertility during childbearing. China's infertile population has exceeded 50 million. Since the "three-child policy" in 2021, the share of third-child births rose rapidly from 11.1% in 2020 to 15% in 2022, with the highest third-and-above birth rates among women aged 30-34, who—due to declining physiological function—largely need assisted reproduction. China's assisted-reproductive market has grown at a CAGR of 14.5% over the past five years, with the market size forecast to reach the hundred-billion level.

Supply-Demand Gap, Strong Overseas Demand

China's assisted-reproductive market currently faces a large supply-demand gap. Penetration is low, yet leading institutions are still "fully booked," mainly due to the difficulty of obtaining licenses and the slow pace of talent training. Fewer than 100 institutions nationwide hold PGD/PGS (third-generation IVF) licenses, mostly public hospitals; private or privately funded reproductive institutions account for less than 10%. Current domestic success rates are about 40-60%, while major global markets such as the US and Thailand reach 70-80%. In price, a domestic third-generation IVF cycle costs roughly 90,000-120,000 yuan, versus about 100,000-130,000 yuan in Thailand—little difference.

Differentiated Needs: Single Parenting, Healthy Birth

For example, needs such as sex selection, twins, single-woman egg freezing, and single-parent childbirth—many clients choose overseas treatment because of domestic policy restrictions.

One-Click Join, Easy Start, Global Resources

Mature team, global partnership—join in one click and share the hundred-billion market!

What You Get

[Full-Cycle Support]